Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/14/13 → 5/14/16 |
Funding
- Quintiles, Inc. (GS-US-342-0109 // GS-US-342-0109)
- Gilead Sciences, Inc (GS-US-342-0109 // GS-US-342-0109)
Prot # GS-US-342-0109: A Phase 2, Multicenter, Randomized, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir + GS-5816 for 12 Weeks in Treatment-Experienced Subjects with Chronic HCV Infection
- Flamm, Steven L (PD/PI)
Project: Research project